MEDI-FUTURE, Inc. and Korea Electrotechnology Research Institute (KERI) today had a Kick-off meeting on technology transferring of Digital Breast Tomosynthesis (DBT).

A Tomosynthesis product, a global next-generation product, will be developed due to this DBT technology

transferring. Therefore, a road map for the development of the Tomosynthesis product was announced at

the meeting where all the partners of MEDI-FUTURE, Inc. and the persons concerned of KERI attended.

Through the convergence of the authorized technology of KERI and advanced developing skills of MEDI-FUTURE,

Inc., it is expected that a globally differentiated DBT system will be developed and commercialized very soon.

MEDI-FUTURE, Inc., which is rapidly growing by broadening the dominance of global market, will build up the

foundation of more advanced technologies in the field of breast-care and will solidify its status 

as a specialized global women’s health care company.

 MEDI-FUTURE is a global healthcare IT company dedicated to women's breast care.

 Create Women's Health and Beauty